The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Indorama Ventures PCL 9-Day RSI Related Terms
INDOY vs DOW: 9-Day RSI Comparison
For the Chemicals subindustry, Indorama Ventures PCL's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indorama Ventures PCL 9-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Indorama Ventures PCL's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Indorama Ventures PCL's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indorama Ventures PCL (INDOY) has a 9-Day RSI of 99.78 as of Jun. 29, 2026. According to the industry distribution chart, Indorama Ventures PCL ranks #315 out of 1653 companies in the Chemicals industry, placing it in the top 19.1%.
Is Indorama Ventures PCL's 9-Day RSI too high?
Indorama Ventures PCL's current 9-Day RSI is 99.78. The Chemicals industry median 9-Day RSI is 43.96. Indorama Ventures PCL's value of 99.78 is 127% above this industry median. Based on the distribution chart, Indorama Ventures PCL ranks #315 out of 1653 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Indorama Ventures PCL has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Indorama Ventures PCL's 9-Day RSI compare to DOW?
According to the Chemicals industry distribution chart, Indorama Ventures PCL ranks #315 out of 1653 companies for 9-Day RSI. This places Indorama Ventures PCL in the top 19% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 43.96. Indorama Ventures PCL's value of 99.78 is 127% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Chemicals company?
The median 9-Day RSI among Chemicals companies is 43.96, based on 1,653 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indorama Ventures PCL's current 9-Day RSI of 99.78 is 127% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median 9-Day RSI is 43.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indorama Ventures PCL's current 9-Day RSI is 99.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indorama Ventures PCL stock overvalued right now?
Indorama Ventures PCL (INDOY) has a current 9-Day RSI of 99.78. The stock's GF Value™ is $6.56, compared to a current price of $7.03 — trading 7.2% above its estimated fair value. The current 9-Day RSI is 99.78 and 127% above the Chemicals industry median of 43.96. Indorama Ventures PCL's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Indorama Ventures PCL (INDOY), the current 9-Day RSI is 99.78 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indorama Ventures PCL (INDOY) Overvalued in 2026?
Based on GuruFocus' analysis, Indorama Ventures PCL stock appears to be overvalued.
The current stock price of $7.03 is trading 7.2% above its estimated GF Value™ of $6.56.
Key valuation signals for INDOY:
9-Day RSI: 99.78
GF Value™: $6.56 vs. price of $7.03 (7.2% above fair value)
Industry Position: 127% above the Chemicals median (#315 of 1653)
No single metric tells the full story. See the INDOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indorama Ventures PCL is engaged in the manufacture and distribution of Polyethylene Terephthalate, Purified Terephthalic Acid, Paraxylene, recycling, Purified Isophthalic Acid, Naphthalene Dicarboxylate, PET preforms and packaging, Integrated EG, Integrated purified EO, PO/MTBE, Integrated Surfactants comprising EOA, LAB and others, Fibers including Polyester, Rayon, Nylon, Polypropylene, composites and worsted wool fibers products. The company operates in three reportable segments Combined PET, Integrated Oxides and Derivatives and Fibers. The maximum revenue is derived from the Combined PET segment.
72GF Score
Get the complete analysis for INDOY
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INDOY has been successfully added to your 